Alnylam Pharmaceuticals, Inc.
Oligonucleotide end caps

Last updated:

Abstract:

Modified nucleic acids are described herein, including pharmaceutical compositions comprising the modified nucleic acids, and methods of using the modified nucleic acids.

Status:
Grant
Type:

Utility

Filling date:

25 Oct 2016

Issue date:

20 Aug 2019